Approvals for Gene-Based Therapy: Navigating Through Uncharted Waters

Gene-based therapies are members of a larger therapeutic category characterized as advanced therapy medicinal products (ATMP). Most stakeholders recognize the potential impact of new gene-based therapies: improved outcomes and quality of life for patients with some of the most complex and chronic genetic conditions, which can be presented with considerable clinical variation. 

(Click to Enlarge Pages)